SCHEMBL21628867

SCHEMBL21628867

COC(=O)c1cnc(Oc2ccc(C(F)(C(F)(F)F)C(F)(F)F)cc2)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.49
PTGER4 P35408 1/20 0.41
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
PDGFRB P09619 1/20 0.39
KDR P35968 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
LIPE Q05469 3/20 0.37
MAPK1 P28482 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MAOB P27338 1/20 0.36
P2RY1 P47900 1/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628667 0.91 LMNA (0.49) LMNAPTGER4KMT2AATMPDGFRB
SCHEMBL21628650 0.90 LMNA (0.57) LMNAPTGER4KMT2AATMPDGFRB
SCHEMBL21628605 0.88 LMNA (0.47) LMNAPTGER4KMT2AATMPDGFRB
SCHEMBL21628440 0.88 LMNA (0.48) LMNAPTGER4KMT2AHPGDMAPT
SCHEMBL21628570 0.87 LMNA (0.46) LMNAPTGER4KMT2AATMPDGFRB
SCHEMBL21628678 0.87 MAOB (0.50) LMNAKMT2AMAPTL3MBTL1MAOB
SCHEMBL21628409 0.87 HPGD (0.44) LMNAPTGER4SMN1; SMN2HPGDLIPE
SCHEMBL21628893 0.86 PTGER4 (0.45) PTGER4MRGPRX4SMN1; SMN2
SCHEMBL21628802 0.86 HDAC6 (0.44) PTGER4
SCHEMBL21628879 0.85 SMN1; SMN2 (0.41) PTGER4KMT2AKDRSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK LMNA 3083/4885PTGER4 4252/4885KMT2A 248/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885PTGER4 4387/4885KMT2A 313/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885PTGER4 4387/4885KMT2A 313/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK LMNA 3327/4885PTGER4 4387/4885KMT2A 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.